Position:
Chief Executive Officer and Director at Fennec Pharmaceuticals Inc
Location:
Greater Boston, United States
Found email addresses for Jeff Hackman:
Found phone for Jeff Hackman:
Aug 2024 - Current
Sep 2021 - Aug 2024
Dec 2018 - Jun 2021
Nov 2017 - Dec 2018
Jun 2016 - Nov 2017
Jul 2015 - Jun 2016
Oct 2012 - Jul 2015
Mar 2009 - Nov 2012
Jan 2006 - Jan 2008
Jan 2001 - Jan 2006
Their professional focus is Biotechnology, Clinical Development, and Clinical Trials across 3 core areas.
BA at Lycoming College
What is Jeff Hackman's email address?
SignalHire found a verified business email address for Jeff Hackman: j******n@fennecpharma.com.What is Jeff Hackman's phone number?
SignalHire found a verified phone number for Jeff Hackman: +1-***-***-4242.How do I contact Jeff Hackman at Fennec Pharmaceuticals Inc?
You can reach Jeff Hackman through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.What is Jeff Hackman's professional background?
Jeff Hackman has 25 years of professional experience. They have held roles including Chairman and CEO, President, North America, and Interim CEO and Chief Operating Officer at companies such as Comera Life Sciences, EUSA Pharma, and Novelion Therapeutics. Their education includes BA from Lycoming College.Is Jeff Hackman's contact information up to date?
Yes. Jeff Hackman's SignalHire profile was last updated on 29 December 2025, reflecting their current position as Chief Executive Officer and Director at Fennec Pharmaceuticals Inc in Research Triangle Park, United States.SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.